Red Blood Cell Membrane-Camouflaged Reduction-Responsive Polyethylenimine-Based Nanoparticles for Enhanced Antitumor Efficacy of Antisense Oligonucleotides
- 29 July 2025
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (9) , 5458-5472
Abstract
As a potential drug, antisense oligonucleotides (AO) have considerable application prospects in the field of tumor treatment. However, the main problem to be solved is the lack of an efficient and safe carrier that contributes to reaching the target cancer cells and utilizing the antitumor effect of AO. Here, we designed and developed a novel AO delivery system, which was based on a modified polyethylenimine (PEI) named TPGS-SS-PEI by connecting tocopherol polyethylene glycol succinate (TPGS) to PEI through the disulfide bond (SS) and the biomimetic red blood cell membrane vesicles (RVs). R-TSP/AO was composed of an AO-loaded micelle (TSP/AO) as the "core" prepared by TPGS-SS-PEI, and RVs as the "shell". The formulations and properties of R-TSP/AO were optimized and characterized. The mean particle size and zeta potential of R-TSP/AO were 109.7 nm and -24.10 mV, respectively. In vitro studies indicated that R-TSP/AO was sensitive to highly reducing conditions and exhibited excellent stability and high security. In addition, R-TSP showed higher AO transfection efficiency and excellent gene silencing efficiency compared with unmodified PEI (P < 0.001). R-TSP/AO exhibited potent tumor inhibition (55.65%) in 4T1 tumor-bearing mice without inducing systemic toxicity. These findings suggested that R-TSP/AO was safe and efficient in enhancing the antitumor efficacy and R-TSP had the potential to be further researched as a carrier for nucleic acid drugs delivery.Keywords
Funding Information
- Shanxi Medical University (CKD/SXMU-2024-12)
- Applied Basic Research Project of Shanxi Province, China (202203021221190, 202403021211153)
This publication has 35 references indexed in Scilit:
- Metal-Coordinated Histidine-Functionalized Redox-Responsive Polyethyleneimine as a Smart Gene Delivery VectorMolecular Biotechnology, 2025
- Targeting the tumor microenvironment with mesenchymal stem cells based delivery approach for efficient delivery of anticancer agents: An updated reviewBiochemical Pharmacology, 2024
- Hybrid membrane based biomimetic nanodrug with high-efficient melanoma-homing and NIR-II laser-amplified peroxynitrite boost properties for enhancing antitumor therapy via effective immunoactivationBiomaterials, 2024
- Carbohydrate polymer-based nanoparticles with cell membrane camouflage for cancer therapy: A reviewInternational Journal of Biological Macromolecules, 2024
- PEI functionalized cell membrane for tumor targeted and glutathione responsive gene deliveryInternational Journal of Biological Macromolecules, 2023
- Development of a biomimetic DNA delivery system by encapsulating polyethyleneimine functionalized silicon quantum dots with cell membranesColloids and Surfaces B: Biointerfaces, 2023
- Evolution of nanomedicine formulations for targeted delivery and controlled releaseAdvanced Drug Delivery Reviews, 2023
- Design of red blood cell membrane-cloaked dihydroartemisinin nanoparticles with enhanced antimalarial efficacyInternational Journal of Pharmaceutics, 2022
- Red blood cells membrane‐derived nanoparticles: Applications and key challenges in their clinical translationWIREs Nanomedicine and Nanobiotechnology, 2022
- A novel reduction-sensitive modified polyethylenimine oligonucleotide vectorInternational Journal of Pharmaceutics, 2015